Fulvestrant plus anastrozole for metastatic breast cancer

被引：3
|
作者：
Burki, Talha Khan
机构：
来源：
LANCET ONCOLOGY | 2019年 / 20卷 / 05期
关键词：
D O I：
10.1016/S1470-2045(19)30217-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E247 / E247
页数：1
相关论文
共 50 条
  • [1] Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer
    Mehta, Rita S.
    Barlow, William E.
    Albain, Kathy S.
    Vandenberg, Ted A.
    Dakhil, Shaker R.
    Tirumali, Nagendra R.
    Lew, Danika L.
    Hayes, Daniel F.
    Gralow, Julie R.
    Linden, Hannah H.
    Livingston, Robert B.
    Hortobagyi, Gabriel N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (13): : 1226 - 1234
  • [2] Anastrozole and Fulvestrant in Metastatic Breast Cancer REPLY
    Mehta, Rita S.
    Barlow, William E.
    Hortobagyi, Gabriel N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (17): : 1663 - 1664
  • [3] Combination Anastrozole and Fulvestrant in Metastatic Breast Cancer
    Mehta, Rita S.
    Barlow, William E.
    Albain, Kathy S.
    Vandenberg, Ted A.
    Dakhil, Shaker R.
    Tirumali, Nagendra R.
    Lew, Danika L.
    Hayes, Daniel F.
    Gralow, Julie R.
    Livingston, Robert B.
    Hortobagyi, Gabriel N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (05): : 435 - 444
  • [4] Randomized phase II trial of gefitinib plus anastrozole or fulvestrant in postmenopausal, metastatic breast cancer
    Carlson, R. W.
    O'Neill, A.
    Vidaurre, T.
    Gomez, H. L.
    Badve, S.
    Sledge, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer (vol 380, pg 1226, 2019)
    Lindens, Hannah
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (23): : 2282 - 2282
  • [6] Fulvestrant plus capivasertib for metastatic breast cancer
    Dekker, Tim Johannes Adrianus
    LANCET ONCOLOGY, 2020, 21 (05): : E232 - E232
  • [7] Fulvestrant plus capivasertib for metastatic breast cancer Reply
    Jones, Robert H.
    Casbard, Angela
    Carucci, Margherita
    Foxley, Andrew
    Howell, Sacha J.
    LANCET ONCOLOGY, 2020, 21 (05): : E234 - E234
  • [8] Fulvestrant outperforms anastrozole in advanced breast cancer
    Jancin, Bruce
    JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2015, 13 (01): : 33 - 33
  • [9] A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefitinib in the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer
    Robert W. Carlson
    Anne O’Neill
    Tatiana Vidaurre
    Henry L. Gomez
    Sunil S. Badve
    George W. Sledge
    Breast Cancer Research and Treatment, 2012, 133 : 1049 - 1056
  • [10] A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefitinib in the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer
    Carlson, Robert W.
    O'Neill, Anne
    Vidaurre, Tatiana
    Gomez, Henry L.
    Badve, Sunil S.
    Sledge, George W.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 133 (03) : 1049 - 1056
12345